Day One Biopharmaceuticals (DAWN) Amortizatization of Intangibles (2022 - 2025)
Historic Amortizatization of Intangibles for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Q3 2025 value amounting to $800000.0.
- Day One Biopharmaceuticals' Amortizatization of Intangibles rose 3333.33% to $800000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 13017.52%. This contributed to the annual value of $6.4 million for FY2024, which is 3660.45% down from last year.
- Day One Biopharmaceuticals' Amortizatization of Intangibles amounted to $800000.0 in Q3 2025, which was up 3333.33% from $800000.0 recorded in Q2 2025.
- Over the past 5 years, Day One Biopharmaceuticals' Amortizatization of Intangibles peaked at $5.3 million during Q2 2023, and registered a low of $47000.0 during Q1 2022.
- In the last 4 years, Day One Biopharmaceuticals' Amortizatization of Intangibles had a median value of $800000.0 in 2025 and averaged $1.5 million.
- In the last 5 years, Day One Biopharmaceuticals' Amortizatization of Intangibles surged by 404094.49% in 2023 and then plummeted by 9429.55% in 2024.
- Day One Biopharmaceuticals' Amortizatization of Intangibles (Quarter) stood at $1.7 million in 2022, then fell by 8.74% to $1.6 million in 2023, then surged by 79.12% to $2.8 million in 2024, then plummeted by 71.66% to $800000.0 in 2025.
- Its Amortizatization of Intangibles stands at $800000.0 for Q3 2025, versus $800000.0 for Q2 2025 and $4.2 million for Q1 2025.